Dr. Nima Sharifi, MD of Cleveland Clinic comments on how investigators are now looking to use new therapies earlier within prostate cancer disease states which may be more effective from ASCO GU 2016.
Advertisement
[the_ad id="32629"]
Investigators looking to use new therapies earlier within prostate cancer disease states which may be more effective
By Editor